Cabaletta Bio · 3 days ago
Associate Scientist, Process Development
Wonder how qualified you are to the job?
BiotechnologyHealth Care
Insider Connection @Cabaletta Bio
Responsibilities
Execute process development experimental plans, provide associated protocols and final reports as needed, and present updates and data to teams.
Accurately capture data in a timely manner, ensuring data integrity and protocol compliance.
Maintain all individual training requirements in a compliant state.
Support phase-appropriate cell therapy production processes using QbD principles.
Identify and evaluate new technologies to improve manufacturing outcomes such as: reduced costs, increased throughput, and enhanced quality.
Maintain laboratory material and sample inventory, support the planning of process development materials needs and coordinate purchasing with lab manager.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
B.S. with 3 + years or M.S. with 1 + years’ experience within biologics process development and manufacturing under cGMP processes.
Previous experience and working knowledge of T-cells or immunological cell therapies.
Experience with cell therapy manufacturing scale up, and process development and optimization is required.
Experience in flow cytometry and cell-based bioassays is a plus.
Good working knowledge in cGMP manufacturing of biological process and ICH regulations.
Good coordination and communication skills are required.
Highly organized and efficient, able to work independently. Strong problem-solving skill is preferred.
Ability to coordinate parallel tasks across multiple projects, demonstrating prioritization.
Benefits
Competitive benefits
PTO
Stock option plans
Company
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Funding
Current Stage
Public CompanyTotal Funding
$210MKey Investors
5AM Ventures
2023-05-17Post Ipo Equity· $87M
2022-12-08Post Ipo Equity· $35M
2020-11-10Post Ipo Equity· Undisclosed
Recent News
2024-06-04
Investing.com
2024-06-04
Company data provided by crunchbase